Cardio3 Biosciences SA

(CIBSF)

By |

Profile

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
City / Town: Mont-Saint-Guibert
Country: BEL
Postal Code: 1435

Issuer Information

Exchange: OTO
CEO: Christian Homsy
Employees: 77


Gathering Data... Please wait

Profile

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
City / Town: Mont-Saint-Guibert
Country: BEL
Postal Code: 1435

Issuer Information

Exchange: OTO
CEO: Christian Homsy
Employees: 77
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 70.80 52 Wk Low 44.67
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,942,344.00 EPS (TTM) -7.39 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 80 80 80 80
Low Target Price Estimate 80 80 80 80
Mean Target Price Estimate 80 80 80 80
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/06/15 04/06/15 04/06/15 04/06/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 1 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 0